FIELD: chemistry.
SUBSTANCE: present invention relates to a salt of phosphoric acid or a salt of tartaric acid alkylcarbamoyl naphthalenyloxyoxytenoyl hydroxy amide of formula (1), where R1 is C1-3-alkyl substituted with one substitute selected from di-C1-3-alkylamino. Invention also relates to a method of producing said salts.
[Formula 1]
EFFECT: technical result is obtaining novel salts of alkylcarbamoyl naphthalenyloxyoctenone hydroxy amide with improved stability and hygroscopicity, which can be used in medicine as an antitumour agent.
8 cl, 8 tbl, 2 ex, 5 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION CONTAINING ALKYLCARBAMOYLNAPHTHALENYLOXY-OCTOYLHYDROXYAMIDE PHOSPHATE, ALKYLCARBAMOYLNAPHTHALENYLOXYOXTENOYLHYDROXYAMIDE TARTRATE OR COMBINATION THEREOF, AND METHOD FOR PRODUCTION THEREOF | 2019 |
|
RU2816889C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING HDAC INHIBITOR AND ANTI-PD1 ANTIBODY OR ANTI-PD-L1 ANTIBODY | 2020 |
|
RU2824577C1 |
| NITROGEN-CONTAINING AROMATIC DERIVATIVES, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF, METHOD FOR TREATMENT AND USING | 2003 |
|
RU2310651C2 |
| AMINO ACID DERIVATIVES AND PHARMACEUTICALLY ACCEPTABLE BASIC SALTS THEREOF METHODS OF PREPARING AMINO ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITION HAVING ANTIVIRAL ACTIVITY | 1992 |
|
RU2109731C1 |
| PYRIMIDINE SUBSTITUTED MACROCYCLIC HCV INHIBITORS | 2008 |
|
RU2481340C2 |
| APPLICATION OF AGONIST-LIGAND SPECIFIC FOR RAR-γ,-TYPE RECEPTORS FOR APOPTOSIS RATE INCREASE | 1996 |
|
RU2188037C2 |
| TETRALIN AND INDANE DERIVATIVES AND USE THEREOF AS 5-HT ANTAGONISTS | 2005 |
|
RU2388748C2 |
| ANTIBACTERIAL AGENT | 2000 |
|
RU2269525C2 |
| AROMATIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF | 1996 |
|
RU2198878C2 |
| PYRAZOLE COMPOUND AND ITS PHARMACEUTICAL USE | 2012 |
|
RU2617678C2 |
